Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 346-351

  Bulcao, Christian F ^a   D'Souza, Karen M ^a   Malhotra, Ricky ^b   Staron, Michelle ^b   Duffy, Jody Y ^a   Pandalai, Prakash K ^a   Jeevanandam, Valluvan ^b   Akhter, Shahab A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

apoptosis; cytokines; donor heart dysfunction; heart transplantation; inflammation; nitric oxide

Indexed keywords

CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; JANUS KINASE 2; NITRIC OXIDE; PROTEIN BNIP3; STAT3 PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MALE; MUSCLE FIBER CONTRACTION; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADULT; BRAIN DEATH; CASPASE 3; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TISSUE DONORS;

EID: 77349111033     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.09.007     Document Type: Article

References (27)

1. Halejcio-Delophont P., Siaghy E.M., Devaux Y., et al. Consequences of brain death on coronary blood flow and myocardial metabolism. Transplant Proc 30 (1998) 2840-2841
2. White M., Wiechmann R.J., Roden R.L., et al. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 92 (1995) 2183-2189
3. Pandalai P.K., Lyons J.M., Duffy J.Y., et al. Role of the β-adrenergic receptor kinase in myocardial dysfunction following brain death. J Thorac Cardiovasc Surg 130 (2005) 1183-1189
4. McLean K.M., Duffy J.Y., Pandalai P.K., et al. Glucocorticoids alter the balance between pro- and anti-inflammatory mediators in the myocardium in an experimental model of brain death. J Heart Lung Transplant 26 (2007) 78-84
5. Birks E.J., Burton P.B.J., Owen V., et al. Elevated tumor necrosis factor-α and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 suppl III (2000) III-352-III-358
6. Oral H., Dorn G.W., and Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272 (1997) 4836-4842
7. Birks E.J., Yacoub M.H., Burton P.S.J., et al. Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 70 (2000) 1498-1506
8. i and cell contraction in cultured chick ventricular myocytes. Circ Res 75 (1994) 285-295
9. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
10. Yu X.W., Kennedy R.H., and Liu S.J. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 278 (2003) 16304-16309
11. Cai J. Thoracic transplantation in the United States: an analysis of UNOS registry data. Clin Transplant (2006) 41-56
12. Salim A., Martin M., Brown C., et al. Complications of brain death: frequency and impact on organ retrieval. Am Surg 72 (2006) 377-381
13. Fischer P., and Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res Cardiol 102 (2007) 279-297
14. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95 (2004) 187-195
15. Wang Z.Y., Jiang B.B., and Brecher P. Selective inhibition of STAT3 phosphorylation by sodium salicylate in cardiac fibroblasts. Biochem Pharmacol 63 (2002) 1197-1207
16. Buttman M., Berberich-Siebelt F., Serfling E., et al. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. J Vasc Res 44 (2007) 51-60
17. McCormick J., Barry S.P., Sivarajah A., et al. Free radical scavenging inhibits STAT3 phosphorylation following in vivo ischemia/reperfusion injury. FASEB J 20 (2006) 2115-2117
18. Steele I.C., Nugent A.M., Maguire S., et al. Cytokine profile in chronic cardiac failure. Eur J Clin Invest 26 (1996) 1018-1022
19. Roig E., Orus J., Pare C., et al. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 82 (1998) 688-690
20. Satoh M., Tamura G., Segawa I., et al. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch Int J Pathol 427 (1996) 503-509
21. Guillen I., Blanes M., Gomez-Lechon M.J., et al. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol 269 (1995) R229-R235
22. Neumann F.-J., Ott I., Gawaz M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
23. Sawa Y., Ichikawa H., Kagisaki K., et al. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116 (1998) 511-517
24. Wan S., DeSmet J.M., Barvais L., et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112 (1996) 806-811
25. An H.-J., Maeng O., Kang K.-H., et al. Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem 281 (2006) 33939-33948
26. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
27. Burzotta F., Iacoviello L., Di Castelnuovo A., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88 (2001) 1125-1128